Universitätsklinikum Schleswig-Holstein (UKSH)


Klinik

Standort der Organisation:
Lübeck / Kiel, Deutschland


Publikationen in Kooperation mit FAU-Wissenschaftern


Go to first page Go to previous page 1 von 10 Go to next page Go to last page
Wunderle, M., Pretscher, J., Brucker, S.Y., Volz, B., Hartmann, A., Fiessler, C.,... Rauh, C. (2019). Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment, 174(2), 453-461. https://dx.doi.org/10.1007/s10549-018-05115-6
Scheer, M., Vokuhl, C., Blank, B., Hallmen, E., Von Kalle, T., Muenter, M.,... Koscielniak, E. (2019). Desmoplastic small round cell tumors: Multimodality treatment and new risk factors. Cancer Medicine, 8(2), 527-542. https://dx.doi.org/10.1002/cam4.1940
Oosterhaven, J.A.F., Uter, W., Aberer, W., Armario-Hita, J.C., Ballmer-Weber, B.K., Bauer, A.,... Grabbe, J. (2019). European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis. Contact Dermatitis, 80(5), 263-272. https://dx.doi.org/10.1111/cod.13192
Piroth, M.D., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R.,... Sauer, R. (2019). Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention. Strahlentherapie und Onkologie, 195(1), 1-12. https://dx.doi.org/10.1007/s00066-018-1378-z
Lehnert, H., & Sieber, C. (2019). Metabolic disorders. Internist, 60(2), 113-114. https://dx.doi.org/10.1007/s00108-019-0554-2
Moreira, A., Loquai, C., Pfoefer, C., Kaehler, K.C., Knauss, S., Heppt, M.V.,... Heinzerling, L. (2019). Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. European journal of cancer, 106, 12-23. https://dx.doi.org/10.1016/j.ejca.2018.09.033
Hadji, P., Stoetzer, O., Decker, T., Kurbacher, C.M., Marme, F., Schneeweiss, A.,... Tesch, H. (2019). The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial. Journal of Bone Oncology, 14. https://dx.doi.org/10.1016/j.jbo.2018.09.010
Kucharzik, T., Dignass, A.U., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K.,... Siegmund, B. (2019). Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS): AWMF Registry 021/009. Zeitschrift für Gastroenterologie, 57(2), 162-241. https://dx.doi.org/10.1055/a-0824-0861
Arnold, M., Bach, C., Heinemann, F.M., Horn, P.A., Ziemann, M., Lachmann, N.,... Spriewald, B.M. (2018). Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival. International Journal of Immunogenetics. https://dx.doi.org/10.1111/iji.12363
Satzger, I., Momma, M., Thoms, K.M., Eigentler, T., Schultz, E., Loquai, C.,... Gutzmer, R. (2018). Characterization of Checkpoint Inhibitor-associated Diabetes mellitus - Experience in 12 Patients. (pp. 15-16).
Wermann, W.K., Viardot, A., Kayser, S., Alakel, N., Elmaagacli, A., Faul, C.,... Goekbuget, N. (2018). Comorbidities Are Frequent in Older Patients with De Novo Acute Lymphoblastic Leukemia (ALL) and Correlate with Induction Mortality: Analysis of More Than 1200 Patients from GMALL Data Bases. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
Saussele, S., Hehlmann, R., Fabarius, A., Jeromin, S., Proetel, U., Rinaldetti, S.,... Lauseker, M. (2018). Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV. Leukemia, 32(5), 1222-1228. https://dx.doi.org/10.1038/s41375-018-0055-7
Yeomans, D.C., Meidahl, A., Eisenried, A., Klukinov, M., & Tzabazis, A. (2018). Effect of Nasal Oxytocin on Pain Following Traumatic Brain Injury in Rats. (pp. 1336-1336).
Fasching, P., Laible, M., Weber, K.E., Wirtz, R.M., Denkert, C., Schlombs, K.,... Untch, M. (2018). Evaluation of the MammaTyperVR as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes. In ANNALS OF ONCOLOGY (pp. 73-73). Munich, DE: OXFORD: OXFORD UNIV PRESS.
Wagner, T., Augustin, M., Blome, C., Forschner, A., Garbe, C., Gutzmer, R.,... Kaehler, K.C. (2018). Fear of cancer progression in patients with stage IA malignant melanoma. European Journal of Cancer Care, 27(5). https://dx.doi.org/10.1111/ecc.12901
Suttorp, M., Schulze, P., Glauche, I., Goehring, G., Von Neuhoff, N., Metzler, M.,... Thiede, C. (2018). Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial. Leukemia, 32(7), 1657-1669. https://dx.doi.org/10.1038/s41375-018-0179-9
Suttorp, M., Metzler, M., Millot, F., Shimada, H., Bansal, D., Gunes, A.M.,... Schrappe, M. (2018). Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients. Pediatric Blood & Cancer, 65(12). https://dx.doi.org/10.1002/pbc.27431
Stickel, F., Buch, S., Nischalke, H.D., Weiss, K.H., Gotthardt, D., Fischer, J.,... Hampe, J. (2018). Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. American Journal of Gastroenterology, 113(10), 1475-1483. https://dx.doi.org/10.1038/s41395-018-0041-8
Mitzel-Rink, H., Hassel, J., Berking, C., Gutzmer, R., Heinzerling, L., Majenka, P.,... Loquai, C. (2018). Hyponatremia and Nephritis - Rare Side Effects of Checkpoint Inhibitors in Patients with metastatic Melanoma. (pp. 15-15).
Krug, D., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R.,... Sauer, R. (2018). Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer : A systematic review. Strahlentherapie und Onkologie, 194(7), 607-618. https://dx.doi.org/10.1007/s00066-018-1270-x

Zuletzt aktualisiert 2016-11-05 um 13:31